Rtw Investments, LP Uro Gen Pharma Ltd. Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Rtw Investments, LP holds 3,787,347 shares of URGN stock, worth $42.3 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
3,787,347
Previous 3,557,347
6.47%
Holding current value
$42.3 Million
Previous $59.7 Million
19.42%
% of portfolio
0.77%
Previous 1.0%
Shares
5 transactions
Others Institutions Holding URGN
# of Institutions
130Shares Held
35.9MCall Options Held
22KPut Options Held
93.8K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.74MShares$41.7 Million0.09% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$25.7 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$24.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.18MShares$24.3 Million0.0% of portfolio
-
Cowen And Company, LLC1.8MShares$20 Million0.59% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $254M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...